Cognition Therapeutics
CGTX
CGTX
37 hedge funds and large institutions have $13.3M invested in Cognition Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.28% less ownership
Funds ownership: 23.87% → 23.59% (-0.28%)
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$213K | |
| 2 | +$102K | |
| 3 | +$75.2K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.1K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$52.8K |
Top Sellers
| 1 | -$322K | |
| 2 | -$96.2K | |
| 3 | -$86.7K | |
| 4 |
NCM
Neumann Capital Management
Foster City,
California
|
-$48.1K |
| 5 |
RCG
Rock Creek Group
Washington,
District of Columbia
|
-$14.7K |